Michael Palfreyman
Technik-/Wissenschafts-/F&E-Leiter bei Amorsa Therapeutics, Inc.
Vermögen: 337 921 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Alex Nivorozhkin | M | 64 |
Amorsa Therapeutics, Inc.
 Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The company is based in Southborough.
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | 4 Jahre |
| Greene Brett | M | - |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | 4 Jahre |
| George Lasezkay | M | 72 |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 12 Jahre |
| Gaston Matthyssens | M | - |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 13 Jahre |
| Geert-Jan Mulder | M | 58 |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 9 Jahre |
| Eric So | M | 49 |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | - |
| Douglas Drysdale | M | 54 |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | - |
| Jean Marie Stassen | M | - |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 11 Jahre |
| John Kanakis | M | 44 |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | - |
| Kieran Rooney | M | - |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 11 Jahre |
| Barbara Leyman | M | - |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 10 Jahre |
| Paul Glavine | M | 35 |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Elizabeth Tallett | F | 74 |
The University of Nottingham
| 4 Jahre |
| Imran ibni Almarhum Tuanku Ja’afar | M | 76 |
The University of Nottingham
| 3 Jahre |
| Anthony Joseph Lloyd | M | 74 |
The University of Nottingham
| 4 Jahre |
| Andrew O. Watson | M | - |
The University of Nottingham
| 4 Jahre |
| Malcolm Barrett | M | - |
The University of Nottingham
| 4 Jahre |
| Ek Kia Tan | M | 76 |
The University of Nottingham
| 4 Jahre |
| Ariffin bin Khalid | M | 80 |
The University of Nottingham
| 4 Jahre |
| Stephen Pakola | M | 55 |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | 3 Jahre |
| David C. Press | M | 78 |
The University of Nottingham
| 4 Jahre |
| John Dean | M | - |
The University of Nottingham
| 4 Jahre |
| Keith Hamill | M | 72 |
The University of Nottingham
| 4 Jahre |
| Mark Edward Chapman | M | 71 |
The University of Nottingham
| 4 Jahre |
| Bruce Murdoch | M | - |
The University of Nottingham
| 4 Jahre |
| John Richard Coomber | M | 75 |
The University of Nottingham
| 4 Jahre |
| Andrew Poolman | M | - |
The University of Nottingham
| 4 Jahre |
| Anthony Floyd | M | 74 |
The University of Nottingham
| 4 Jahre |
| John W. Lydall | M | 79 |
The University of Nottingham
| 4 Jahre |
| Paul Davison | M | 70 |
The University of Nottingham
| 4 Jahre |
| Michael Stewart Hodgkinson | M | 80 |
The University of Nottingham
| 3 Jahre |
| Anita Gupta | M | - |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The company is based in Southborough. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 18 | 56,25% |
| Vereinigte Staaten | 7 | 21,88% |
| Belgien | 7 | 21,88% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Palfreyman
- Persönliches Netzwerk
